Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 2
1961 2
1963 2
1964 1
1966 3
1968 1
1970 1
1971 3
1972 2
1974 1
1975 1
1976 3
1977 1
1979 1
1980 1
1982 1
1983 1
1984 3
1985 1
1986 1
1987 2
1988 1
1989 1
1990 1
1991 2
1995 1
1997 1
1999 3
2001 2
2002 2
2006 2
2007 2
2008 2
2009 2
2010 3
2011 2
2012 1
2013 3
2014 1
2015 3
2016 4
2017 1
2019 1
2020 1
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC.
Cho BC, Lu S, Felip E, Spira AI, Girard N, Lee JS, Lee SH, Ostapenko Y, Danchaivijitr P, Liu B, Alip A, Korbenfeld E, Mourão Dias J, Besse B, Lee KH, Xiong H, How SH, Cheng Y, Chang GC, Yoshioka H, Yang JC, Thomas M, Nguyen D, Ou SI, Mukhedkar S, Prabhash K, D'Arcangelo M, Alatorre-Alexander J, Vázquez Limón JC, Alves S, Stroyakovskiy D, Peregudova M, Şendur MAN, Yazici O, Califano R, Gutiérrez Calderón V, de Marinis F, Passaro A, Kim SW, Gadgeel SM, Xie J, Sun T, Martinez M, Ennis M, Fennema E, Daksh M, Millington D, Leconte I, Iwasawa R, Lorenzini P, Baig M, Shah S, Bauml JM, Shreeve SM, Sethi S, Knoblauch RE, Hayashi H; MARIPOSA Investigators. Cho BC, et al. N Engl J Med. 2024 Oct 24;391(16):1486-1498. doi: 10.1056/NEJMoa2403614. Epub 2024 Jun 26. N Engl J Med. 2024. PMID: 38924756 Clinical Trial.
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.
Yang JC, Lu S, Hayashi H, Felip E, Spira AI, Girard N, Kim YJ, Lee SH, Ostapenko Y, Danchaivijitr P, Liu B, Alip A, Korbenfeld E, Mourão Dias J, Besse B, Passaro A, Lee KH, Xiong H, How SH, Cheng Y, Chang GC, Yoshioka H, Thomas M, Nguyen D, Ou SI, Mukhedkar S, Prabhash K, D'Arcangelo M, Alatorre-Alexander J, Vázquez Limón JC, Alves S, Stroyakovskiy D, Peregudova M, Şendur MAN, Yazici O, Califano R, Gutiérrez Calderón V, de Marinis F, Kim SW, Gadgeel SM, Owen S, Xie J, Sun T, Mehta J, Venkatasubramanian R, Ennis M, Fennema E, Daksh M, Roshak A, Man J, Knoblauch RE, Bauml JM, Baig M, Shah S, Sethi S, Cho BC; MARIPOSA Investigators. Yang JC, et al. N Engl J Med. 2025 Oct 30;393(17):1681-1693. doi: 10.1056/NEJMoa2503001. Epub 2025 Sep 7. N Engl J Med. 2025. PMID: 40923797 Clinical Trial.
The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLC.
Gray JE, Schenker M, Şendur MAN, Leonova V, Kowalski D, Kato T, Orlova R, Yang JC, Langleben A, Pilz A, Ungureanu A, Mak MP, De Angelis F, Aggarwal H, Zimmer Z, Zhao B, Shamoun M, Kim TM. Gray JE, et al. Among authors: leonova v. J Thorac Oncol. 2025 Feb;20(2):219-232. doi: 10.1016/j.jtho.2024.10.026. Epub 2024 Nov 7. J Thorac Oncol. 2025. PMID: 39521434 Free article. Clinical Trial.
Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus Chemotherapy.
Hochmair M, Schenker M, Cobo Dols M, Kim TM, Ozyilkan O, Smagina M, Leonova V, Kato T, Fedenko A, De Angelis F, Rittmeyer A, Gray JE, Greystoke A, Aggarwal H, Huang Q, Zhao B, Lara-Guerra H, Nadal E. Hochmair M, et al. Among authors: leonova v. J Thorac Oncol. 2025 Feb;20(2):203-218. doi: 10.1016/j.jtho.2024.10.012. Epub 2024 Oct 28. J Thorac Oncol. 2025. PMID: 39477187 Free article. Clinical Trial.
Fibrin self-assembly is adapted to oxidation.
Rosenfeld MA, Bychkova AV, Shchegolikhin AN, Leonova VB, Kostanova EA, Biryukova MI, Sultimova NB, Konstantinova ML. Rosenfeld MA, et al. Among authors: leonova vb. Free Radic Biol Med. 2016 Jun;95:55-64. doi: 10.1016/j.freeradbiomed.2016.03.005. Epub 2016 Mar 9. Free Radic Biol Med. 2016. PMID: 26969792
The oxidative modification of cellular fibrin-stabilizing factor.
Rosenfeld MA, Shchegolikhin AN, Leonova VB, Kostanova EA, Biryukova MI, Bychkova AV, Konstantinova ML, Vasilyeva AD. Rosenfeld MA, et al. Among authors: leonova vb. Dokl Biochem Biophys. 2016 Mar;467(1):128-31. doi: 10.1134/S1607672916020149. Epub 2016 May 20. Dokl Biochem Biophys. 2016. PMID: 27193716
[Peptides of the "middle molecule" group].
Galaktionov SG, Tseĭtin VM, Leonova VI, Nikolaĭchik VV, Mikhneva LM. Galaktionov SG, et al. Among authors: leonova vi. Bioorg Khim. 1984 Jan;10(1):5-17. Bioorg Khim. 1984. PMID: 6385990 Review. Russian.
Ozone-induced oxidative modification of fibrinogen molecules.
Rosenfeld MA, Shchegolikhin AN, Bychkova AV, Leonova VB, Biryukova MI, Kostanova EA, Konstantinova ML. Rosenfeld MA, et al. Among authors: leonova vb. Biochemistry (Mosc). 2013 Oct;78(10):1171-9. doi: 10.1134/S000629791310012X. Biochemistry (Mosc). 2013. PMID: 24237152
81 results